Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, what steps his Department plans to take to ensure that patients with multiple myeloma have access to extending medicines after treatments for that condition are removed from the Cancer Drugs Fund in November 2015.

NHS England has advised that a draft treatment pathway for patients with multiple myeloma is currently in the process of being finalised. This has been the subject of public consultation and is being revised to take into account the comments received and the potential impact of treatments removed from the Cancer Drugs Fund.

The treatment pathway is likely to be published early in 2016.